A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus

NCT04515849 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

248

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Chronic Kidney Diseases

Interventions

DRUG: Cotadutide 100 micrograms
DRUG: Cotadutide 300 micrograms
DRUG: Cotadutide 600 micrograms
DRUG: Semaglutide
DRUG: Placebo

Sponsor

AstraZeneca